Among the safety stocks discussed by Cramer during the episode on May 14, Bristol-Myers Squibb Company (NYSE:BMY) was first ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

Shares of Bristol Myers Squibb Co. rose 3.83% to $45.81 Thursday, on what proved to be an all-around great trading session ...

It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...

Ten years after heading to Cannes with Alexander Payne's ‘Nebraska,' Squibb is back with ‘Eleanor the Great’ from director ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...

Shares of Bristol Myers Squibb Co. BMY slipped 1.55% to $46.88 Thursday, on what proved to be an all-around positive trading ...

The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...